Description: Phoenix Biotech Acquisition Corp. - Unit, a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities.
2201 Broadway
Oakland,
CA
94612
United States
Phone:
215 731 9450
Officers
| Name | Title |
|---|---|
| Mr. Christopher B. Ehrlich M.B.A. | CEO & Director |
| Dr. Douglas Carl Fisher M.B.A, M.B.A., M.D. | Pres |
| Mr. Daniel E. Geffken M.B.A., MBA | Chief Financial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-10-06 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |